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The Association Between Subclinical Hypothyroidism and Erectile Dysfunction  Dr Noman Aslam1      Dr Waheed ur Rehman2      Dr Qazi Muhammad Ibrahim3 1.House Officer Holy Family Hospital,  Rawalpindi 2.House Officer Lahore General Hospital, Lahore 3.House Officer Services Institute Of Medical Sciences, Lahore  Abstract Objective: To assess the association between subclinical hypothyroidism and erectile dysfunctionStudy Design: cross sectional study.Study Place and Duration: department of General Medicine at Lahore General Hospital Lahore, Services Hospital Lahore and Holy Family Hospital Rawalpindi from January 2018 to June 2018Material and methods: A total number of 180 subjects were involved in this study. The study patients were categorized into three groups’ i.e. erectile dysfunction with sub clinical hypothyroidism, erectile dysfunction with euthyroidism and controls with euthyroidism. Data was subjected statistical analysis with the help of computer software SPSS version 23. Mean±S.D was calculated for quantitative variables. For qualitative variables, frequency and percentages were calculated. Independent t test and Chi square was applied to assess the statistical difference. P value of less than or equal to 0.05 was considered as statistically significant.Results: The difference between the ED with SCH group and the ED with euthyroidism group was statistically insignificant for FT3 (p=0.135) and E2 (p=0.318). The difference between the ED with SCH group and the controls with euthyroidism group was statistically significant except FT3 (p=0.098).Conclusion: Patients with erectile dysfunction commonly present with subclinical hypothyroidism and it can be concluded that subclinical hypothyroidism is associated with erectile dysfunction. However severity of erectile dysfunction is not associated to subclinical hypothyroidism. From the results of this study, recommendations regarding the need of thyroid function screening for men presenting with erectile dysfunction can be made. Keywords: Subclinical Hypothyroidism, Erectile Dysfunction, Euthyroidism, Thyroid, thyroxine, triiodothyronine  Introduction Recurrent or consistent inability to maintain or attain erection of the penis for proper sexual intercourse is termed as erectile dysfunction 1. In US 30 million or more males suffer from erectile dysfunction as shown by many epidemiological studies 2. Similarly in three major cities of China Beijing, Guangzhou and Chongqing prevalence of erectile dysfunction is reported to be 26.1% 3. Erection of penis involves hormonal as well as psychogenic input and is considered a very complex process 4. Risk factors associated with erectile dysfunction include hypogonadism, endocrine disorders, thyroid diseases and hyperprolactinemia 5, 6. Thyroid function failure is very largely associated with erectile dysfunction; ratio of erectile dysfunction is reported to be 52.1% in hypothyroidism 7, 8. Mild thyroid failure is known as subclinical hypothyroidism and its diagnosis is based upon elevation of thyroid stimulating hormone in serum along with normal concentrations of free thyroxine or FT4. This mild form of hypothyroidism has the capacity to advance towards overt hypothyroidism. Studies on the epidemiology of hypothyroidism show that prevalence of subclinical hypothyroidism is much more as compared to the prevalence of overt hypothyroidism. Prevalence of subclinical hypothyroidism ranges from 3.4% to 5.8% while prevalence of overt hypothyroidism ranges from 0.03% to 0.7% 9. In this study association of subclinical hypothyroidism with erectile dysfunction was assessed. Not many studies provide such data in this region of the world. Therefore there is a need to find the association between subclinical hypothyroidism and erectile dysfunction.  Material and Method This study was performed at department of General Medicine at Lahore General Hospital Lahore, Services Hospital Lahore and Holy Family Hospital Rawalpindi from January 2018 to June 2018. This was a cross sectional study. Ethical approval was obtained from the Hospital Ethics Committee. Inclusion was based upon the following criteria; patients with erectile dysfunction, in the age group of 18-65 years and having normal sexual hormones. Exclusion from this study was based upon the following criteria; patients with the history of previous over hypothyroidism, patients currently suffering from overt hypothyroidism, patient with previous or current hyperthyroidism, patient who undergone neck surgery previously, patients who had radioactive iodine therapy or thyroidectomy, patients with diabetes mellitus, patients suffering from any chronic illnesses like renal insufficiency, liver failure or any other systemic disease, patients treated with PDE5 inhibitors or sexual hormones within last three months patients with chronic wasting disease. Control group consisted of males belonging to the age group of 18-65 years and having normal thyroid 
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homes in their serum. Members of the control group were excluded on the basis of the same criteria that have been mentioned above. Written informed consent was taken from all the participants of the study. A total number of 180 subjects were involved in this study. Sample size was calculated from the reference study conducted by Dawei Chen et al 10. Non probability consecutive type of sampling technique was used to collect the sample. Baseline measurements involved, FT3 (free triiodothyronine) FT4 (free thyroxine), PRL (prolactin), TSH (thyroid stimulating hormone), TT (total testosterone) and E2 (estradiol). The study patients were categorized into three groups i.e. erectile dysfunction with sub clinical hypothyroidism, erectile dysfunction with euthyroidism and controls with euthyroidism. Measurements were carried out with the help of electrochem-iluminescence immunoassay. Normal range of thyroid stimulating hormone was 0.27-4.7 mU\L, free thyroxine 12.0-22.0 pmol\L, free triiodothyronine 3.60-7.50 pmol\L, prolactin 4.6-31.4 ng\ml, and total testosterone 2.49 to 8.36 ng per ml and estradiol 7.63 to 42.59 pg per ml. Patients with concentration of thyroid stimulating hormone greater than 4.2 mU\L and normal concentrations of free thyroxine and triiodothyronine were diagnosed with sub clinical hypothyroidism. Control group patients had normal thyroxine concentrations, normal triiodothyronine and normal thyroid stimulating hormone levels in their serum and were termed as euthyroid. Diagnosis of erectile dysfunction was carried out with the help of IIEF-5 questionnaire (International Index of Erectile Function). Data thus obtained from all measurements and questionnaire was then subjected statistical analysis with the help of computer software SPSS version 23 Mean±S.D was calculated for quantitative variables. For qualitative variables, frequency and percentages were calculated. Independent t test and Chi square was applied to assess the statistical difference between groups. P value ≤0.05 was considered as significant.  Results One hundred and eighty patients were included in this study. The study patients were categorized into three groups i.e. erectile dysfunction with sub clinical hypothyroidism, erectile dysfunction with euthyroidism and controls with euthyroidism. The mean age and BMI of the ED with SCH group was 30.61±3.68 years and 23.70±2.11 kg/m2respectively.n=25 (56.8%) were previous smokers and n=19 (43.2%) were current smokers. While, the mean age and BMI of the ED with euthyroidism group was 32.67±3.11 years and 24.11±2.71 kg/m2respectively. n=52 (56.5%) were previous smokers and n=40 (43.5%) were current smokers. The difference was statistically insignificant except age (p=0.001). (Table I) The mean IIEF-5 scores, TSH, FT3, FT4, TT, E2 and PRL of the ED with SCH group was10.23±3.04, 5.68±2.01(mU/l), 5.34±0.94 (pmol/I), 16.16±1.80 (PMOL/I), 5.31±1.49 (ng/ml), 31.52±7.20 (pg/ml) and 11.71±3.60(ng/ml) respectively. While, the mean IIEF-5 scores, TSH, FT3, FT4, TT, E2 and PRL of the ED with euthyroidism group was 11.42±4.20,2.18±0.92(mU/l),5.53±0.54(pmol/I), 16.98±1.67(PMOL/I), 4.71±1.17(ng/ml), 32.45±3.66 (pg/ml) and 9.01±2.75(ng/ml) respectively. The difference was statistically insignificant for FT3 (p=0.135) and E2 (p=0.318). (Table II) The mean age and BMI of the ED with SCH group was 30.61±3.68 years and 23.70±2.11 kg/m2respectively.n=25 (56.8%)were previous smokers and n=19 (43.2%)were current smokers. While, the mean age and BMI of the controls with euthyroidism group was 33.50±4.04 years and 24.56±1.91 kg/m2respectively. n=27 (61.4%) were previous smokers and n=17 (38.6%) were current smokers. The difference was statistically significant except (p=0.664). (Table III) The mean IIEF-5 scores, TSH, FT3, FT4, TT, E2 and PRL of the ED with SCH group was 10.23±3.04, 5.68±2.01 (mU/l), 5.34±0.94 (pmol/I), 16.16±1.80 (PMOL/I), 5.31±1.49 (ng/ml), 31.52±7.20 (pg/ml) and 11.71±3.60 (ng/ml) respectively. While, the mean IIEF-5 scores, TSH, FT3, FT4, TT, E2 and PRL of the controls with euthyroidism group was 22.75±0.62, 2.36±0.99(mU/l), 5.61±0.53(pmol/I), 18.18±1.41(PMOL/I), 4.36±1.16(ng/ml), 35.54±5.71 (pg/ml) and 8.79±2.08(ng/ml) respectively. The difference was statistically significant except FT3 (p=0.098). (Table IV). Table I Demographic Characteristics Variable Erectile Dysfunction with Subclinical hypothyroidism n=44 Erectile dysfunction with Euthyroidism n=92 P-value Age (yrs) 30.61±3.68 32.67±3.11 0.001 BMI 23.70±2.11 24.11±2.71 0.387 Smoking Current n=19 (43.2%) n=40 (43.5%) 0.246 Previous n=25 (56.8%) n=52 (56.5%)    
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Table II Variable Erectile Dysfunction with Subclinical hypothyroidism n=44 Erectile dysfunction with Euthyroidism n=92 P-value IIEF-5 scores 10.23±3.04 11.42±4.20 0.000 Thyroid Stimulating Hormone (mU/l) 5.68±2.01 2.18±0.92 0.000 FT3(pmol/I) 5.34±0.94 5.53±0.54 0.135 FT4(PMOL/I) 16.16±1.80 16.98±1.67 0.009 TT(ng/ml) 5.31±1.49 4.71±1.17 0.010 E2(pg/ml) 31.52±7.20 32.45±3.66 0.318 Prolactin(ng/ml) 11.71±3.60 9.01±2.75 0.000  Table III Demographic Characteristics Variable Erectile Dysfunction with Subclinical hypothyroidism n=44 Controls with Euthyroidism n=44 P-value Age (Yrs) 30.61±3.68 33.50±4.04 0.000 BMI 23.70±2.11 24.56±1.91 0.047 Smoking Current n=19 (43.2%) n=17 (38.6%) 0.664 Previous n=25 (56.8%) n=27 (61.4%)  Table. IV Variable Erectile Dysfunction with Subclinical hypothyroidism n=44 Controls with Euthyroidism n=44 P-value IIEF-5 scores 10.23±3.04 22.75±0.62 0.000 Thyroid Stimulating Hormone (mU/l) 5.68±2.01 2.36±0.99 0.000 FT3(pmol/I) 5.34±0.94 5.61±0.53 0.098 FT4(PMOL/I) 16.16±1.80 18.18±1.41 0.000 TT(ng/ml) 5.31±1.49 4.36±1.16 0.001 E2(pg/ml) 31.52±7.20 35.54±5.71 0.005 Prolactin(ng/ml) 11.71±3.60 8.79±2.08 0.000  Discussion After the exclusion of the subjects who had normal concentrations of sex hormones, the frequency of patients with subclinical hypothyroidism presenting with erectile dysfunction was reported to be around 24.44%. This ratio is much more as compared to the prevalence of subclinical hypothyroidism among men with erectile dysfunction reported in previous epidemiological studies 11. Thyroid failure is largely associated with erectile dysfunction 12. Studies have reported that prevalence of erectile dysfunction among patients with subclinical hypothyroidism is much more as compared to ratio of erectile dysfunction in healthy euthyroid males 13. Current study has the same results showing that IIEF-5 scores were much lower in patients with subclinical hypothyroidism as compared to the males with euthyroidism. Thus it can be established that mild thyroid failure is commonly associated with erectile dysfunction in males with normal sex hormone concentrations. However exact mechanism of this relation between erectile dysfunction and subclinical hypothyroidism is still unknown. On the other hand it has also stated that sub clinical hypothyroidism along with the evidence of elevated thyroid stimulating hormone is also related to the erectile dysfunction. The mechanism behind this is that elevated thyroid stimulating hormone results in reduction of biological activity of Luteinizing Hormone and also inhibit the secretion of Gonadotropin releasing hormone, which play an important role in human sexual intercourse 14. Moreover elevated levels of thyroid stimulating hormone also result in endothelial dysfunction resulting in reduced formation and availability of nitric oxide and it’s a fact that nitric oxide plays a vital role in vascular system and relaxation of corporal muscle to sustain and attain the penile erection 15, 16, 17 and 18. Studies have showed that receptors for thyroid hormone are also present in smooth muscles and 
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